Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part II)

The second part of this review on eosinophils focuses on biological cell functions and surveys the various deleterious mechanisms involved in the eosinophil-dominated inflammatory reaction. It discusses the possible pathogenic role of eosinophils in several eosinophil-related diseases, such as parasitic infections, interstitial lung disorders and bronchial diseases, such as parasitic infections, interstitial lung disorders and bronchial diseases, graft rejection, vasculitic granulomatous disorders, pleural effusion, and bronchogenic tumours. The final section of the article highlights the possible recent pharmacological and future therapeutic approaches in modifying eosinophil recruitment and function.

This article has been cited by other articles:

				S. Pegorier, L. A. Wagner, G. J. Gleich, and M. Pretolani Eosinophil-Derived Cationic Proteins Activate the Synthesis of Remodeling Factors by Airway Epithelial Cells J. Immunol., October 1, 2006; 177(7): 4861 - 4869. [Abstract] [Full Text] [PDF]

				S. D. Swain, N. N. Meissner, and A. G. Harmsen CD8 T Cells Modulate CD4 T-Cell and Eosinophil-Mediated Pulmonary Pathology in Pneumocystis Pneumonia in B-Cell-Deficient Mice Am. J. Pathol., February 1, 2006; 168(2): 466 - 475. [Abstract] [Full Text] [PDF]

				B. Lamkhioued, S. G. Abdelilah, Q. Hamid, N. Mansour, G. Delespesse, and P. M. Renzi The CCR3 Receptor Is Involved in Eosinophil Differentiation and Is Up-Regulated by Th2 Cytokines in CD34+ Progenitor Cells J. Immunol., January 1, 2003; 170(1): 537 - 547. [Abstract] [Full Text] [PDF]

				S. Letuve, A. Druilhe, M. Grandsaigne, M. Aubier, and M. Pretolani Critical Role of Mitochondria, but Not Caspases, during Glucocorticosteroid-Induced Human Eosinophil Apoptosis Am. J. Respir. Cell Mol. Biol., May 1, 2002; 26(5): 565 - 571. [Abstract] [Full Text] [PDF]

				L. ULLER, C. G. A. PERSSON, L. KALLSTROM, and J. S. ERJEFALT Lung Tissue Eosinophils May Be Cleared Through Luminal Entry Rather Than Apoptosis . Effects of Steroid Treatment Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1948 - 1956. [Abstract] [Full Text] [PDF]

				S. Letuve, A. Druilhe, M. Grandsaigne, M. Aubier, and M. Pretolani Involvement of caspases and of mitochondria in Fas ligation-induced eosinophil apoptosis: modulation by interleukin-5 and interferon-{gamma} J. Leukoc. Biol., November 1, 2001; 70(5): 767 - 775. [Abstract] [Full Text] [PDF]

				S. A. Lewis, I. D. Pavord, J. R. Stringer, A. J. Knox, S. T. Weiss, and J. R. Britton The Relation Between Peripheral Blood Leukocyte Counts and Respiratory Symptoms, Atopy, Lung Function, and Airway Responsiveness in Adults Chest, January 1, 2001; 119(1): 105 - 114. [Abstract] [Full Text] [PDF]

				M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]

				I. Sabroe, D. M. Conroy, N. P. Gerard, Y. Li, P. D. Collins, T. W. Post, P. J. Jose, T. J. Williams, C. J. Gerard, and P. D. Ponath Cloning and Characterization of the Guinea Pig Eosinophil Eotaxin Receptor, C-C Chemokine Receptor-3: Blockade Using a Monoclonal Antibody In Vivo J. Immunol., December 1, 1998; 161(11): 6139 - 6147. [Abstract] [Full Text] [PDF]

				T. B. van Dijk, E. Caldenhoven, J. A.M. Raaijmakers, J.-W. J. Lammers, L. Koenderman, and R. P. de Groot The Role of Transcription Factor PU.I in the Activity of the Intronic Enhancer of the Eosinophil-Derived Neurotoxin (RNS2) Gene Blood, March 15, 1998; 91(6): 2126 - 2132. [Abstract] [Full Text] [PDF]

				M. McKinnon, K. Page, I. J. Uings, M. Banks, D. Fattah, A. E.I. Proudfoot, P. Graber, C. Arod, R. Fish, T. N.C. Wells, et al. An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils J. Exp. Med., July 7, 1997; 186(1): 121 - 129. [Abstract] [Full Text] [PDF]